- Diagnostics
- Thursday, 25 Jun 2020
New Noninvasive Nutritional Testing with Metabolomix+
Genova Diagnostics introduces a new collect-at-home nutritional test to help support telemedicine practices and provide clinicians a more comprehensive set of options without a blood draw. The Metabolomix+ profile is a unique combination of nutritional tests that assess the functional need for antioxidants, B-vitamins, minerals, digestive support and amino acids with add-on modules based on a patient's unique needs. Add-on modules include bloodspot essential and metabolic fatty acids, toxic and nutrient elements, as well as genomics.
The Metabolomix+ profile identifies complex nutritional insufficiencies that may underlie chronic conditions and helps inform a treatment plan to optimize health outcomes. Testing can assist in evaluation of many areas including fatigue, mood disorders, dietary guidance, athletic performance, weight loss and digestive complaints.
Chief Scientific Officer, Dr. Amy Peace Brewer shared, "The study of metabolomics is all encompassing - organic acids, amino acids, fatty acids, stool metabolites, hormone metabolites, and more. Genova Diagnostics has been an industry leader in metabolomic testing for decades. Our newest profile, Metabolomix+, is a modular profile allowing clinicians to build their own version of metabolomic testing based on clinical need. As an added benefit, it can be collected in the comfort of the patient's home, at their convenience."
Related Industry Updates
IV Equipment Market Share, Growth by Top Company, Application, Driver, Trends & Forecasts by 2027
Mar 26, 2021
ArcherDX Receives Approval for Archer®MET Companion Diagnostic for TEPMETKO® (Tepotinib) in Advanced Non-Small Cell Lung Cancer in Japan
Mar 25, 2020
Huami partners with Nanshan Zhong's team to fight COVID-19 coronavirus in a joint laboratory
Apr 13, 2020
Europe Surety Market to Witness an Outstanding Growth During 2020 With Top Key Players are CNA Financial Corporation,The Travelers Indemnity Company,Liberty Mutual Insurance Company,Chubb
Oct 26, 2020
Yuyu Pharma will export COVID-19 test sets from SD BIOSENSOR to the world market
Jun 18, 2020
Leader of leading Rare Disease Company (CENTOGENE) enters in the Finals of EY Entrepreneur of the Year 2019
Sep 23, 2019
Rochester RHIO Turns to eHealth Technologies to Deliver Solutions for 3D Image Sharing
Mar 06, 2020